Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain
- PMID: 16638164
- PMCID: PMC2870431
- DOI: 10.1017/S0950268805005571
Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain
Abstract
This study analysed the role of several risk factors for hospitalization due to community-acquired, respiratory syncytial virus (RSV) infection. The risk factors detected in infants hospitalized for RSV infection in the first 24 months of life were compared with those in the general infant population in our region. There were 361 episodes of hospitalization in 357 infants. Eighty per cent of the infants did not present underlying conditions for severe RSV infection and only 10 (3%) were candidates for palivizumab prophylaxis. In multivariate analysis, birthweight of <2500 g was independently associated with hospitalization for RSV infection and was the most commonly detected medical risk factor. Other risk factors were maternal age at delivery <25 years, birth in the second half of the year, prematurity, suburban residence and congenital heart disease. In conclusion, together with well-known risk factors, we found that low birthweight was an independent factor for severe RSV infection.
Figures
Similar articles
-
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.Pediatr Infect Dis J. 2003 Sep;22(9):823-7. doi: 10.1097/01.inf.0000086403.50417.7c. Pediatr Infect Dis J. 2003. PMID: 14506376
-
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.Pediatrics. 1998 Sep;102(3 Pt 1):531-7. Pediatrics. 1998. PMID: 9738173 Clinical Trial.
-
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54. doi: 10.1097/01.inf.0000053885.34703.84. Pediatr Infect Dis J. 2003. PMID: 12671452
-
Prevention of respiratory syncytial virus infection with palivizumab.Monaldi Arch Chest Dis. 2000 Aug;55(4):333-8. Monaldi Arch Chest Dis. 2000. PMID: 11057088 Review.
-
Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?Clin Ther. 2004 Dec;26(12):2130-7. doi: 10.1016/j.clinthera.2004.12.005. Clin Ther. 2004. PMID: 15823776 Review.
Cited by
-
Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.PLoS One. 2016 Sep 30;11(9):e0163567. doi: 10.1371/journal.pone.0163567. eCollection 2016. PLoS One. 2016. PMID: 27689356 Free PMC article.
-
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.J Glob Health. 2015 Dec;5(2):020416. doi: 10.7189/jogh.05.020416. J Glob Health. 2015. PMID: 26682048 Free PMC article.
-
Respiratory viral coinfection among hospitalized patients with H1N1 2009 during the first pandemic wave in Brazil.Braz J Infect Dis. 2012 Mar-Apr;16(2):180-3. doi: 10.1016/s1413-8670(12)70302-1. Braz J Infect Dis. 2012. PMID: 22552462 Free PMC article.
-
A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life.Eur J Pediatr. 2008 Oct;167(10):1125-33. doi: 10.1007/s00431-007-0643-4. Epub 2008 Jan 3. Eur J Pediatr. 2008. PMID: 18172683 Free PMC article.
-
Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department.Medicine (Baltimore). 2018 Mar;97(9):e0057. doi: 10.1097/MD.0000000000010057. Medicine (Baltimore). 2018. PMID: 29489664 Free PMC article.
References
-
- Simoes EAF. Respiratory syncytial virus infection. Lancet. 1999;354:847–852. - PubMed
-
- Hall CB, McCarthy CA, Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 6th edn. Vol. 2. Philadelphia, PA: Elsevier, Churchill Livingstone; 2005. Respiratory syncytial Virus; pp. 2008–2026.
-
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143:S127–S132. - PubMed
-
- Boyce TG, Mellen BG, Mitchell EF, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr. 2000;137:865–870. - PubMed
-
- Weigl JA, Puppe W, Schmidt HJ. Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur J Clin Microbiol Infect Dis. 2001;20:452–459. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical